As of June 2026, the FDA's December 2024 Pharmacy Compounding Advisory Committee evaluation concluded that the criteria weighed against placing AOD-9604 (free base) or AOD-9604 acetate on the 503A Bulks List, and AOD-9604 is currently listed as Nominated but Withdrawn from FDA Category 2
Each milliliter contains sterile water for injection with 0.9% benzyl alcohol as a preservative, helping to maintain sterility for multiple withdrawals from the same vial
$14.99 Vial LC-526 Metabolic Complex Epitalon 10MG SSJ-9 Amino Matrix Acetic Acid Solution Survodutide 10MG SELANK Mazdutide 10MG L-Glutathione 1500MG HCG 10000iu Cerebrolysin 60MG BAC Water 30ML GLOW 70MG KLOW 80 Tesamorelin (10MG) NAD+ Reta GLP-3R BPC-157 (10MG) Cagrilintide Tre FOXO4-DRI (10MG) Testagen (20MG) SS-31 (10MG) Kisspeptin-10 (10MG) Thymalin (10MG) GHK-Cu (100MG) DSIP (5MG) Wolverine Blend (10MG) BAC Water (3ML) Ipamorelin (10MG) TB-500 (10MG) BAC Water (10ML) AOD-9604 (5MG) Ipa / CJC 10mg MOTS-C (10MG) CJC-1295 (10MG) PT-141 (10MG) Tirz GLP-2 (10MG) Bacteriostatic Water (10mL) is sterile water containing 0.9% benzyl alcohol as a preservative, used as a diluent for peptide reconstitution in laboratory research
was supported by NASA through the NASA Hubble Fellowship grant #HST-HF2-51570.001-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Incorporated, under NASA contract NAS5-26555
When the GLOW Blend's components work synergisticallyGHK-Cu suppressing inflammatory gene transcription, BPC-157 generating anti-inflammatory NO while modulating cytokine profiles, and TB-500 inhibiting NF-B signaling while promoting M2 macrophage polarizationthe result represents comprehensive inflammatory control operating at genetic, molecular, and cellular levels to create optimal conditions for tissue regeneration in research models